Nuzenio

Ustekinumab

Ustekinumab news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 3 latest news signals 3 publisher sources 100/100 entity strength

Latest news

Severe Dupilumab-Associated Psoriasis Flare After Switching From Ustekinumab for Biopsy-Proven Eczematous Dermatitis: A Case Report - CureusCureus · Sun, 09 Aug 2026 13:27:03 GMT Health Canada Approves Biocon’s Ustekinumab Autoinjector - Pearce IPPearce IP · Wed, 29 Jul 2026 07:00:00 GMT Biocon Gets Health Canada Approval For Yesintek Ustekinumab Autoinjector To Treat Autoimmune Diseases - SahiSahi · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Sun, 09 Aug 2026 13:27:03 GMTSevere Dupilumab-Associated Psoriasis Flare After Switching From Ustekinumab for Biopsy-Proven Eczematous Dermatitis: A Case Report - Cureus

Wed, 29 Jul 2026 07:00:00 GMTHealth Canada Approves Biocon’s Ustekinumab Autoinjector - Pearce IP

Wed, 29 Jul 2026 07:00:00 GMTBiocon Gets Health Canada Approval For Yesintek Ustekinumab Autoinjector To Treat Autoimmune Diseases - Sahi

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Associated Psoriasis Flare2 live mentions After Switching From2 live mentions Biopsy2 live mentions Proven Eczematous Dermatitis2 live mentions A Case Report2 live mentions Severe Dupilumab1 live mentions Cureus Severe Dupilumab1 live mentions Cureus Cureus1 live mentions Health Canada Approves1 live mentions Biocon1 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ustekinumab.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

3 distinct publisher/source names are currently connected to this entity page.